Business
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Resu...

About this update from Oncolytics Biotech Inc.
[{"type":"text","content":"\n \n \n \n Oncolytics Biotech® to Host Conference Call to Discuss Second Quarter Financial Results and Recent Operational Highlights\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nPADDING-RIGHT:0.17em; PADDING-LEFT:0.17em; VERTICAL-ALIGN: BOTTOM; BORDER-TOP:black 1pt; BORDER-RIGHT:black 1pt; BORDER-BOTTOM:black 1pt; BORDER-LEFT:black 1pt\n}\n.prnml4{\nMARGIN-TOP:0em; MARGIN-RIGHT:0em; MARGIN-BOTTOM:0em; MARGIN-LEFT:0.33em !IMPORTANT\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE; BORDER-TOP:1pt black; BORDER-RIGHT:1pt black; BORDER-BOTTOM:1pt black; BORDER-LEFT:1pt black\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n \n \n \n Conference call and webcast to take place on\n \n Thursday, August 11, 2022\n \n , at\n \n 8:30 a.m. ET\n \n \n \n \n \n \n SAN DIEGO, CA\n \n and\n \n CALGARY, AB\n \n \n ,\n \n \n July 27, 2022\n \n \n /CNW/ -- Oncolytics Biotech\n \n ®\n \n Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on\n \n Thursday, August 11, 2022\n \n , at\n \n 8:30 a.m. ET\n \n to discuss a corporate update and financial results for the second quarter of 2022.\n \n \n \n \n \n \n \n \n \n \n \n Conference Call & Webcast\n \n \n \n \n \n Date:\n \n Thursday, August 11, 2022\n \n \n Time:\n \n 8:30 a.m. ET\n \n \n Dial In – North American Toll-Free:\n \n (888) 220-8474\n \n \n Dial In – International:\n \n (647) 484-0475\n \n \n Conference ID\n \n (if needed)\n \n :\n \n 8806-576\n \n \n Webcast:\n \n please\n \n click here\n \n \n \n A webcast of the call will also be available on the Investor Relations page of Oncolytics' website, available by clicking\n \n here\n \n , and will be archived for three months. A dial in replay will be available for one week and can be accessed by dialing (888) 203-1112 (\n \n North America\n \n ) or (647) 436-0148 (International) and using replay code: 8806-576#.\n \n \n \n About Oncolytics Biotech Inc.\n \n \n \n Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. This compound induces anti-cancer immune re...